Jiangsu Recbio reports positive results for adjuvanted recombinant shingles vaccine
According to an interim analysis, healthy individuals aged 40 years and above showed an overall favourable safety and…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
02 Jan 24
According to an interim analysis, healthy individuals aged 40 years and above showed an overall favourable safety and…
26 Dec 23
Karuna is a biopharmaceutical firm focused on the discovery, development and delivery of transformative medicines for individuals with…
22 Dec 23
The authorisation was based on the findings from the Phase 3 SOLSTICE trial in which Livtencity was found…
21 Dec 23
OCE-205 is a therapeutic peptide with a differentiated mechanism of action, designed to relieve portal hypertension while offering…
21 Dec 23
Palatin's focus is solely on its development and clinical pipeline based on the melanocortin receptor system
20 Dec 23
Proceeds expected to be used for stock repurchases and additional royalty and milestone acquisitions
20 Dec 23
Neurogene focused on advancing Phase 1/2 trial for NGN-401, a differentiated clinical stage gene therapy to treat Rett…
19 Dec 23
Manufactured from pooled human plasma from American donors, Alyglo is a liquid solution with 10% immunoglobulin G (100…
19 Dec 23
Most of these products have been developed by Biocon Biologics and are being manufactured at its world-class facilities…
18 Dec 23
The recommendation will be considered by the European Commission in deciding whether to allow Hyqvia for CIDP to…